World of DTC Marketing

JUNE 20, 2022

In addition, the patient journey is different for each product category and audience. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight. Most of the media stories, however, leave out the possible drug side effects, which are serious. TV, alone, is not the answer.

Pharma 210

Pharma Side effects Media Prescription 210

MedCity News

OCTOBER 23, 2024

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

Side effects 108

Side effects Healthcare Provider Education Healthcare 108

World of DTC Marketing

DECEMBER 1, 2021

OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.” ” I understand that DTC marketers are in love with TV even though it’s becoming less effective. On top of these side effects is the common side effect of diarrhea.

Side effects 210

Side effects Doctors Physicians Leads 210

Pharmaceutical Technology

APRIL 24, 2023

Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. Studying the behaviour of animals can aid in drug discovery research too.

Medicine 105

Medicine Side effects Healthcare Healthcare 105

European Pharmaceutical Review

MARCH 21, 2024

What is patient centricity and why is it an important consideration in drug development? Patient centricity is the process of obtaining the patients’ voice and making them active participants; identifying their needs and utilising them to improve decision-making in the healthcare arena.

Healthcare 110

Healthcare Healthcare Patients Medicine 110

European Pharmaceutical Review

NOVEMBER 14, 2022

Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. Indication extension recommendations for 11 medicines.

Medicine 98

Medicine Side effects Safety Pharmaceutical 98

European Pharmaceutical Review

JANUARY 11, 2024

A major limitation is that these drugs generally do not target the specific causes of neuropathic pain, and their efficacy is reduced when the underlying conditions, like nerve damage, cannot be treated effectively. What are the key current challenges in the development of pain medicines? Internet] NIH. cited 2024Jan].

Medicine 102

Medicine Pharmacology Management Side effects 102

World of DTC Marketing

AUGUST 29, 2022

DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. The research showed that patients wanted to understand how the drug works and the potential side effects.

Side effects 203

Side effects Physicians Insurance Marketing 203

European Pharmaceutical Review

DECEMBER 15, 2022

The European Commission (EC) has expanded the marketing authorisation for Dupixent ® (dupilumab) in the European Union (EU), to treat adults with moderate-to-severe prurigo nodularis (PN) who are candidates for systemic therapy, making it the first and only targeted medicine for the condition in Europe and the US.

Medicine 98

Medicine Safety Side effects Patients 98

European Pharmaceutical Review

JULY 20, 2022

Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help regulators determine appropriate risk minimisation measures. ketoconazole – an antifungal medicine. Supporting regulators.

Medicine 97

Medicine Safety Side effects Electronics 97

MedCity News

AUGUST 12, 2022

Liver complications are a known side effect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.

Side effects 96

Side effects Engineering Patients Medicine 96

European Pharmaceutical Review

NOVEMBER 21, 2024

Accessibility, as well as optimised nutrient and medicine release, are the driving forces behind modernising drug delivery. Pills can present significant challenges for certain patients around administration, eg, for those who have difficulty swallowing liquids or solids. Interested? Find out more by completing your details!

52

52

European Pharmaceutical Review

OCTOBER 31, 2022

The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects.

Side effects 98

Side effects Medicine Safety Marketing 98

European Pharmaceutical Review

DECEMBER 18, 2023

After eight weeks of treatment, patients’ depression severity scores dropped by an average of 19.1 Treatment-related side effects included nausea and headache but were generally mild. “As Psychedelic medicines: are they gaining traction in Europe? Participants described generally positive experiences.

Food and Drug Administration 116

Food and Drug Administration Patients Side effects Safety 116

European Pharmaceutical Review

OCTOBER 18, 2024

A new immunotherapy treatment regimen (nivolumab plus doxorubicin, vinblastine, and dacarbazine (AVD)) provided a significant survival rate in advanced Hodgkin lymphoma patients, Phase III trial data shows. Key study findings Almost 1,000 patients enrolled in the Phase III trial.

Side effects 59

Side effects Food and Drug Administration Food Patients 59

European Pharmaceutical Review

AUGUST 23, 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first treatment for Alzheimer’s in Great Britain that has shown some efficacy in slowing disease progression. Lecanemab is authorised to treat adults with early Alzheimer’s. Lecanemab is subject to additional monitoring.

Patients 52

Patients Consulting Side effects Medicine 52

PM360

JULY 13, 2023

“Drugs don’t work in patients who don’t take them,” C. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. Everett Koop, MD, U.S.

Patients 98

Patients Side effects Insurance Medical 98

European Pharmaceutical Review

DECEMBER 7, 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Comirnaty ® , the Pfizer/BioNTech COVID-19 vaccine for infants and children aged six months to four years in Great Britain. The common, expected side effects were within expectations for a vaccine in this age group.

Food and Drug Administration 98

Food and Drug Administration Patients Side effects Medicine 98

Pharmaceutical Technology

MAY 25, 2023

Adherence to medications – defined as the extent to which patients take medications as prescribed by their healthcare providers – can be a significant clinical challenge. Additionally, it is vital for doctors to routinely review patients’ medications to ensure that they are on the right treatment plan to meet their medical needs.

Medicine 52

Medicine Side effects Healthcare Provider Medical 52

Clarify Health

MAY 25, 2024

From enhancing diagnostic accuracy, to leveraging predictive analytics and developing personalized care plans, to supporting decision making and enhancing patient engagement, the use of AI in healthcare has many promising applications. This, in turn, strengthens market positioning, fosters patient trust, and helps to drive growth.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Management 52

World of DTC Marketing

JULY 1, 2021

Pharma websites, more and more, are becoming less relevant when it comes to intent to ask their doctor about a new drug because they too often are hard to read and don’t answer patients’ questions. Patients want to understand better why their insurance company won’t pay for certain medication or why their co-pay has gone up.

Side effects 217

Side effects Doctors Prescription Media 217

European Pharmaceutical Review

OCTOBER 7, 2024

New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials. Furthermore, 70 percent of these patients had a complete response.

Food and Drug Administration 105

Food and Drug Administration Side effects FDA Food 105

Healthcare Success

OCTOBER 17, 2024

Struggling with burnout while maintaining high-quality healthcare services that patients love? Tune in to our latest podcast as Lee Aase, founder of HELPCare, LLC, shares how he transitioned from his pioneering social media work at Mayo Clinic to lead an innovative membership-based direct-to-patient healthcare business.

Healthcare 113

Healthcare Healthcare Patients Insurance 113

European Pharmaceutical Review

JANUARY 30, 2023

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs. Ultimately, this can lead to a progressive decrease in mobility and other severe impairments.

Side effects 96

Side effects Medicine Marketing Patients 96

Clarivate

JUNE 26, 2023

Obtaining the preferences of patients and their caregivers is not a new concept in healthcare. Increasingly, however, industry guidance documents utilize the term ‘patient preference’ in relation to new drug development and benefit-risk assessment. Health technology assessment (HTA) bodies also have some appetite for this information.

Food and Drug Administration 52

Food and Drug Administration Patients Side effects Medicine 52

MedCity News

JANUARY 30, 2024

By catching the disease early, patients have a higher chance of receiving successful treatment, and the cost of treatment can be significantly reduced. Personalized treatment plans: Treatment plans can vary widely depending on the type of cancer, the stage and the patient’s overall health.

Side effects 125

Side effects Ethics Medical Patients 125

PM360

JULY 13, 2023

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims Grace Lomax, Clinical Director of Patient Connect , part of Clarivate. Little wonder 70% of patients with hypertension remain hypertensive and therefore at risk of myocardial infarctions (MIs) and cerebrovascular accidents.

Patients 98

Patients Education Medical Side effects 98

European Pharmaceutical Review

OCTOBER 9, 2023

A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Comparatively, patients given a placebo had on average 18 percent fewer seizures during the treatment phase of the trial, which lasted eight weeks.

Side effects 110

Side effects Recruitment Safety Medicine 110

PM360

NOVEMBER 29, 2022

1 Yet, most patients haven’t tried prescription therapies, a discovery Phreesia Life Sciences made after surveying 6,780 adults age 18 and older who previously had been diagnosed with or treated for constipation as they checked in for their doctors’ appointments. Address Patients’ Quality of Life. Why the disconnect?

Patients 98

Patients Prescription Doctors Education 98

PM360

JUNE 24, 2024

Enabling Precision Medicine Every stakeholder is going to be impacted. Patients can look forward to electronic assistance that can return their voice or other lost abilities. When entering a patient’s conditions into the chatbot, it responds with a list of recommended drugs.

Healthcare 52

Healthcare Healthcare Patients Side effects 52

European Pharmaceutical Review

SEPTEMBER 20, 2022

The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have announced that biosimilar medicines authorised in the European Union (EU) can now be interchanged with their reference medicine or an equivalent biosimilar product. New regulatory guidance could lead to UK biosimilar boom.

Medicine 98

Medicine Side effects Safety Doctors 98

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 98

Side effects Distribution Safety Patients 98

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment.

Side effects 116

Side effects Patients Medicine Leads 116

pharmaphorum

JANUARY 31, 2023

Medication is a staple of modern medicine, with almost 50% of adults in the United States taking at least one prescription medication. This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients. However, the result of non-adherence is consistent.

Patients 52

Patients Pharma Side effects Education 52

European Pharmaceutical Review

JUNE 19, 2024

A non-chemotherapy multi-drug therapy enabled complete remission in 38 percent of evaluable patients with aggressive B-cell lymphoma, a Phase Ib/II clinical trial shows. Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) were used together in a treatment regimen in 50 patients with diffuse large B-cell lymphoma (DLBCL).

Side effects 98

Side effects Patients Medicine Pharmaceutical 98

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Management 98

Pharmaceutical Technology

JUNE 5, 2023

Results unveiled at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting indicate that some patients with locally advanced rectal cancer can be treated with chemotherapy alone and may not need radiation therapy before surgery. Additionally, the patients had to be candidates for surgery. In the FOLFOX group, 9.1%

Patients 52

Patients Side effects Medicine 52